LOS ANGELES--(BUSINESS WIRE)--Aug. 3, 2006--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today reported financial results for the three months and six months ended June 30, 2006.
